[Clinical manifestations of SARS-CoV-2 infection in children in the middle of pandemic season in a pediatric tertiary center. Report of local COVID Clinical Committee, Hospital de Niños Roberto del Río, Santiago Chile].

BACKGROUND SARS-CoV-2 virus infection responsible for de pandemic in course, is a new clinical and physiopathological entity, whose control is still uncertain till we can provide an effective and universal vaccine. In the beginning it was described as a respiratory disease which affects mainly adults, children can have the disease too and in this group the disease can be different than the adult disease. Acute infection in children is mostly mild and when it requires hospital assistance it resolves with support therapy and without complications most of the time. However, in the Pediatric Inflammatory Multisystemic Syndrome is vital the early clinical suspect and refers to a tertiary center to bring support and properly treatment. AIM To describe the clinical spectrum of SARS-CoV-2 virus disease in a pediatric referral center with the pandemic still in development. METHOD A case series of 537 patients with SARS-CoV-2 infection treated between March 1 and July 15, 2020 is presented with a description of those who were hospitalized. RESULTS 127 (23%) of them were hospitalized and of these 69% were symptomatic. Twenty-six patients (20%) of those hospitalized presented PIMS, only one died for complications of his chronic diseases.

[1]  G. Izquierdo,et al.  Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic , 2020, International Journal of Infectious Diseases.

[2]  Simon Li,et al.  Multisystem Inflammatory Syndrome in U.S. Children and Adolescents , 2020, The New England journal of medicine.

[3]  B. Scholefield,et al.  Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital , 2020, Pediatric Cardiology.

[4]  P. Davies,et al.  Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. , 2020, JAMA.

[5]  M. Yamazaki-Nakashimada,et al.  Multisystem inflammatory syndrome associated with COVID19 in children and adolescents: calling for diagnosis. , 2020, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia.

[6]  A. Topjian,et al.  Multisystem Inflammatory Syndrome in Children During the Coronavirus 2019 Pandemic: A Case Series , 2020, Journal of the Pediatric Infectious Diseases Society.

[7]  E. Parodi,et al.  SARS-CoV-2–Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children , 2020, Pediatrics.

[8]  Y. Xue,et al.  A comparative-descriptive analysis of clinical characteristics in 2019-Coronavirus-infected children and adults. , 2020, Journal of medical virology.

[9]  G. Nunnari,et al.  Outbreak of COVID-19 infection in children: fear and serenity. , 2020, European review for medical and pharmacological sciences.

[10]  Wenjun Liu,et al.  COVID‐19 epidemic: Disease characteristics in children , 2020, Journal of medical virology.

[11]  J. Hageman The Coronavirus Disease 2019 (COVID-19). , 2020, Pediatric annals.

[12]  Yongyan Wang,et al.  Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement , 2020, World Journal of Pediatrics.

[13]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[14]  Leslie Citrome,et al.  Book Review: Pandemic Influenza Preparedness and Response, a WHO Guidance Document , 2010 .

[15]  N. Curtis,et al.  Coronavirus Infections in Children Including COVID-19 An Overview of the Epidemiology , Clinical Features , Diagnosis , Treatment and Prevention Options in Children , 2020 .